Analysis of clinical isolates of extended-spectrum β-lactamase-producing bacteria with developed primer and probe sets to detect bla CTX-M , bla TEM , and bla SHV using a fully automated gene detection system.

In this study, we evaluated extended-spectrum beta-lactamase (ESBL)-producing bacteria with the newly developed primer and probe sets to detect bla(CTX-M), bla(TEM), and bla(SHV) using BD MAX (TM), a fully automated multiplex polymerase chain reaction assay system. In 36 isolates confirmed by whole-genome sequencing to have bla(CTX-M), bla(TEM), or bla(SHV), the developed primer and probe sets accurately detected each gene without being influenced by the presence of other beta-lactamase genes. In nine control strains that do not harbor either bla(CTX-M), bla(TEM), or bla(SHV) no cross-reaction was observed. In 191 strains phenotypically determined to be ESBL-producers by conventional antimicrobial susceptibility tests, 189 strains were bla(CTX-M)-, bla(TEM)-, or bla(SHV)-positive as assessed by BD MAX (TM) using the developed primer and probe sets, and two strains were negative for these genes. Whole-genome sequencing revealed that these two strains were phenotypically false-positive ESBL-producers. The accuracy of the primer and probe sets seems to be satisfactory, and they may be applicable to detect CTX-M-type ESBL-producing bacteria.